Early elaborated TNFa significantly contributed to control of influenza A/PR8 viral replication, as in vivo blockade with anti-TNFa mAb administered prior to and at the time of infection (Fig. 1j) significantly increased lung viral loads at 1 dpi compared to infected and sham treated C57BL/6 controls (Fig. 1k). This evidence concerns the gene TNF and infection.